# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000026
Filing Date
2024-03-12
Accepted
2024-03-11 18:50:04
Documents
5
Period of Report
2024-03-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | a2024-03x13fdasupportsacce.htm | 6-K | 20595
2 | EX-99.1 | exhibit991.htm | EX-99.1 | 14266
3 |  | exhibit991001.jpg | GRAPHIC | 271935
4 |  | exhibit991002.jpg | GRAPHIC | 292840
5 |  | exhibit991003.jpg | GRAPHIC | 303581
| Complete submission text file | 0001345099-24-000026.txt |  | 1232151

Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 24739656
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)